Table 1.

Cross-tabulation of referral cytology results and study cytology results

Study cytology
Referral cytologyStatisticsNILMASC-USLSILASC-HHSIL+MissingTotal
ASC-USn54302219123140
p16/Ki-67+14 (25.93%)8 (26.67%)16 (72.73%)16 (84.21%)12 (100%)1 (33.33%)67 (47.86%)
CIN2+4 (7.41%)2 (6.67%)8 (36.36%)9 (47.37%)10 (83.33%)0 (0%)33 (23.57%)
CIN3+1 (1.85%)1 (3.33%)2 (9.09%)5 (26.32%)3 (25%)0 (0%)12 (8.57%)
LSILn49538821458264
p16/Ki-67+10 (20.41%)23 (43.40%)58 (65.91%)17 (80.95%)42 (93.33%)2 (25%)152 (57.58%)
CIN2+4 (8.16%)6 (11.32%)31 (35.23%)12 (57.14%)36 (80%)2 (25%)91 (34.47%)
CIN3+0 (0%)2 (3.77%)5 (5.68%)1 (4.76%)11 (24.44%)1 (12.50%)20 (7.58%)
ASC-Hn1821141015179
p16/Ki-671 (5.56%)10 (47.62%)12 (85.71%)9 (90%)15 (100%)1 (100%)48 (60.76%)
CIN2+4 (22.2%)4 (19.05%)10 (71.43%)5 (50%)15 (100%)1 (100%)39 (49.37%)
CIN3+1 (5.56%)1 (4.76%)1 (7.14%)2 (20%)5 (33.33%)1 (100%)10 (12.66%)
HSIL+n1381111701114
p16/Ki-67+3 (23.08%)3 (37.50%)8 (72.73%)9 (81.82%)68 (87.14%)1 (100%)92 (80.70)
CIN2+3 (23.08%)3 (37.50%)7 (63.64%)7 (63.64%)63 (90.00%)1 (100%)84 (73.68%)
CIN3+0 (0%)0 (0%)3 (27.27%)4 (36.36%)34 (48.57%)0 (0%)41 (35.96%)
Missingn95329028
p16/Ki-67+0 (0%)3 (60%)1 (33.33%)1 (50%)7 (77.78%)0 (0%)12 (42.86%)
CIN2+0 (0%)1 (20%)0 (0%)1 (50%)9 (100%)0 (0%)11 (39.29%)
CIN3+0 (0%)0 (0%00 (0%)0 (0%)5 (55.56%)0 (0%)5 (17.86%)
TotalN1431171386315113625
p16/Ki-67+28 (19.58%)47 (40.17%)95 (68.84%)52 (82.54%)144 (95.36%)5 (38.46%)371 (59.36%)
CIN2+15 (10.49%)16 (13.68%)56 (40.58%)34 (53.97%)133 (88.08%)4 (30.77%)258 (41.28%)
CIN3+2 (1.40%)4 (3.42%)11 (7.97%)12 (19.05%)58 (38.41%)1 (7.69%)88 (14.08%)